Microbot Medical
MBOT
26 hedge funds and large institutions have $5.52M invested in Microbot Medical in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 6 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
7% more capital invested
Capital invested by funds: $5.16M → $5.52M (+$359K)
7% less funds holding
Funds holding: 28 → 26 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$228K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$92.2K |
| 3 |
OC
Oppenheimer & Co
New York
|
+$27.1K |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$21.7K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$55K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$46K |
| 3 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
-$33K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$25K |
| 5 |
SSG
Summit Securities Group
New York
|
-$6K |
MBOT Hedge Fund Activity: Q3 2013 in Review
26 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2013, worth a combined $5.52M — up 7% from $5.16M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MBOT and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 8 added.
The largest buyer was BlackRock Institutional Trust, adding an estimated $228K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $55K sold.
- 26 institutional investors held Microbot Medical (MBOT) as of Q3 2013, down from 28 in Q2 2013.
- Funds reported $5.52M of Microbot Medical stock for Q3 2013, up 7% quarter-over-quarter.
- 5 funds opened new Microbot Medical positions in Q3 2013 and 6 closed out, a net change of -1 holder.
- The largest Microbot Medical buyer in Q3 2013 was BlackRock Institutional Trust, an estimated $228K added.
- The largest Microbot Medical seller in Q3 2013 was A.R.T. Advisors, an estimated $55K sold.
Based on aggregated 13F filings for Q3 2013.